Data / Form D filings / SINAPIS PHARMA, INC.
SINAPIS PHARMA, INC.: Form D filings
SINAPIS PHARMA, INC., a biotechnology company in Jacksonville, FL, filed 5 Form D notices with the SEC between 2010 and 2014. The latest, on September 19, 2014, reports an offering of $3.5 million with nothing sold yet to 5 investors.
Find out what SINAPIS PHARMA, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4350 PABLO PROFESSIONAL COURT, STE. 200, Jacksonville, FL, 32224
- Phone
- (904) 619-0043
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2009
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1492347
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 19, 2014 | New notice | $3,500,000 | $0 | $3,500,000 | 5 | Yet to occur | sec.gov |
| Apr 24, 2014 | New notice | $6,000,000 | $271,120 | $5,728,880 | 5 | Apr 9, 2014 | sec.gov |
| May 19, 2010 | Amendment | $750,002 | $511,234 | $238,768 | 17 | Sep 30, 2009 | sec.gov |
| May 19, 2010 | New notice | $400,000 | $311,163 | $88,837 | 10 | May 17, 2010 | sec.gov |
| May 19, 2010 | New notice | $750,002 | $511,234 | $238,768 | 17 | Sep 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| DONALD C. PICKER | Executive Officer, Director | |
| ALBERT C. HENRY | Director | |
| JAMES C. FONGER | Executive Officer | |
| HOWARD C. CHANDLER, JR. | Executive Officer, Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
- RHEOS MEDICAL CORP. $387,773 · Oct 7, 2026
- DIGITAL ETHER COMPUTING, LLC $625,000 · Sep 23, 2026
- Jupiter Biomedical Research, Inc. $30,000 · Sep 21, 2026
- Kaida BioPharma Inc. $1.6 million · Sep 1, 2026
- StrataBio Inc. $25,000 · Aug 31, 2026
- LUREX BIO, INC $150,000 · Aug 31, 2026
- EXUMA Biotech Corp. $70 million · Aug 20, 2026
- CRESCEL LLC $1.1 million · Aug 19, 2026
- EnduraFAST Inc. $50,000 · Aug 17, 2026
Every Form D from the week of Sep 15, 2014 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SINAPIS PHARMA, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.